| Year |
Citation |
Score |
| 2020 |
Magaret AS, Jacob ST, Halloran ME, Guthrie KA, Magaret CA, Johnston C, Simon NR, Wald A. Multigroup, Adaptively Randomized Trials Are Advantageous for Comparing Coronavirus Disease 2019 (COVID-19) Interventions. Annals of Internal Medicine. PMID 32525715 DOI: 10.7326/M20-2933 |
0.31 |
|
| 2020 |
Gibson CJ, Huang AJ, Larson JC, Mitchell C, Diem S, Lacroix A, Newton KM, Reed SD, Guthrie KA. Patient-Centered Change in the Day-to-Day Impact of Postmenopausal Vaginal Symptoms: Results from a Multicenter Randomized Trial. American Journal of Obstetrics and Gynecology. PMID 31954158 DOI: 10.1016/J.Ajog.2019.12.270 |
0.306 |
|
| 2020 |
Sohal D, Duong MT, Ahmad SA, Gandhi N, Beg MS, Wang-Gillam A, Wade JL, Chiorean EG, Guthrie KA, Lowy AM, Philip PA, Hochster HS. SWOG S1505: Results of perioperative chemotherapy (peri-op CTx) with mfolfirinox versus gemcitabine/nab-paclitaxel (Gem/nabP) for resectable pancreatic ductal adenocarcinoma (PDA). Journal of Clinical Oncology. 38: 4504-4504. DOI: 10.1200/Jco.2020.38.15_Suppl.4504 |
0.335 |
|
| 2020 |
Meyerhardt JA, Shi Q, Fuchs CS, Niedzwiecki D, Zemla TJ, Kumthekar P, Guthrie KA, Couture F, Kuebler JP, Bendell JC, Kumar P, Lewis DA, Tan BR, Bertagnolli MM, Grothey A, et al. Celecoxib in addition to standard adjuvant therapy with 5-fluorouracil, leucovorin, oxaliplatin (FOLFOX) in stage III colon cancer: Results from CALGB/SWOG 80702. Journal of Clinical Oncology. 38: 4003-4003. DOI: 10.1200/Jco.2020.38.15_Suppl.4003 |
0.348 |
|
| 2019 |
Iqbal S, McDonough S, Lenz HJ, Ilson D, Burtness B, Nangia CS, Barzi A, Schneider CJ, Liu JJ, Dotan E, Guthrie KA, Hochster HS. Randomized, Phase II Study Prospectively Evaluating Treatment of Metastatic Esophageal, Gastric, or Gastroesophageal Cancer by Gene Expression of : SWOG S1201. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1900925. PMID 31815582 DOI: 10.1200/Jco.19.00925 |
0.304 |
|
| 2019 |
Guthrie KA, Caan B, Diem S, Ensrud KE, Greaves SR, Larson JC, Newton KM, Reed SD, LaCroix AZ. Facebook advertising for recruitment of midlife women with bothersome vaginal symptoms: A pilot study. Clinical Trials (London, England). 1740774519846862. PMID 31055949 DOI: 10.1177/1740774519846862 |
0.31 |
|
| 2019 |
Sohal D, McDonough S, Ahmad SA, Gandhi N, Beg MS, Wang-Gillam A, Wade JL, Guthrie KA, Lowy AM, Philip PA, Hochster HS. SWOG S1505: Initial findings on eligibility and neoadjuvant chemotherapy experience with mfolfirinox versus gemcitabine/nab-paclitaxel for resectable pancreatic adenocarcinoma. Journal of Clinical Oncology. 37: 414-414. DOI: 10.1200/Jco.2019.37.4_Suppl.414 |
0.343 |
|
| 2018 |
Diem SJ, Guthrie KA, Mitchell CM, Reed SD, Larson JC, Ensrud KE, LaCroix AZ. Effects of vaginal estradiol tablets and moisturizer on menopause-specific quality of life and mood in healthy postmenopausal women with vaginal symptoms: a randomized clinical trial. Menopause (New York, N.Y.). PMID 29738424 DOI: 10.1097/Gme.0000000000001131 |
0.307 |
|
| 2018 |
Mitchell CM, Reed SD, Diem S, Larson JC, Newton KM, Ensrud KE, LaCroix AZ, Caan B, Guthrie KA. Efficacy of Vaginal Estradiol or Vaginal Moisturizer vs Placebo for Treating Postmenopausal Vulvovaginal Symptoms: A Randomized Clinical Trial. Jama Internal Medicine. PMID 29554173 DOI: 10.1001/Jamainternmed.2018.0116 |
0.332 |
|
| 2018 |
Ramanathan RK, McDonough S, Philip PA, Hingorani SR, Lacy J, Kortmansky JS, Thumar JR, Chiorean EG, Shields AF, Behl D, Mehan PT, Gaur R, Seery TE, Guthrie K, Hochster HS. A phase IB/II randomized study of mFOLFIRINOX (mFFOX) + pegylated recombinant human hyaluronidase (PEGPH20) versus mFFOX alone in patients with good performance status metastatic pancreatic adenocarcinoma (mPC): SWOG S1313 (NCT #01959139). Journal of Clinical Oncology. 36: 208-208. DOI: 10.1200/Jco.2018.36.4_Suppl.208 |
0.331 |
|
| 2017 |
Guthrie KA, Larson JC, Ensrud KE, Anderson GL, Carpenter JS, Freeman EW, Joffe H, LaCroix AZ, Manson JE, Morin CM, Newton KM, Otte J, Reed SD, McCurry SM. Effects of pharmacologic and nonpharmacologic interventions on insomnia symptoms and subjective sleep quality in women with hot flashes: A pooled analysis of individual participant data from 4 MsFLASH trials. Sleep. PMID 29165623 DOI: 10.1093/Sleep/Zsx190 |
0.307 |
|
| 2017 |
Yao JC, Guthrie KA, Moran C, Strosberg JR, Kulke MH, Chan JA, LoConte N, McWilliams RR, Wolin EM, Mattar B, McDonough S, Chen H, Blanke CD, Hochster HS. Phase III Prospective Randomized Comparison Trial of Depot Octreotide Plus Interferon Alfa-2b Versus Depot Octreotide Plus Bevacizumab in Patients With Advanced Carcinoid Tumors: SWOG S0518. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2016704072. PMID 28384065 DOI: 10.1200/Jco.2016.70.4072 |
0.313 |
|
| 2017 |
Sohal D, McDonough SL, Ahmad SA, Gandhi N, Beg MS, Wang-Gillam A, Guthrie KA, Lowy AM, Philip PA, Hochster HS. SWOG S1505: A randomized phase II study of perioperative mFOLFIRINOX vs. gemcitabine/nab-paclitaxel as therapy for resectable pancreatic adenocarcinom. Journal of Clinical Oncology. 35: TPS508-TPS508. DOI: 10.1200/Jco.2017.35.4_Suppl.Tps508 |
0.33 |
|
| 2017 |
Kim RD, McDonough SL, El-Khoueiry AB, Bekaii-Saab TS, Stein S, Sahai V, Keogh GP, Kim EJ, Baron AD, Siegel AB, Barzi A, Guthrie K, Javle MM, Hochster HS. SWOG S1310: Randomized phase II trial of single agent MEK inhibitor trametinib vs. 5-fluorouracil or capecitabine in refractory advanced biliary cancer. Journal of Clinical Oncology. 35: 4016-4016. DOI: 10.1200/Jco.2017.35.15_Suppl.4016 |
0.328 |
|
| 2016 |
Chung V, McDonough S, Philip PA, Cardin D, Wang-Gillam A, Hui L, Tejani MA, Seery TE, Dy IA, Al Baghdadi T, Hendifar AE, Doyle LA, Lowy AM, Guthrie KA, Blanke CD, et al. Effect of Selumetinib and MK-2206 vs Oxaliplatin and Fluorouracil in Patients With Metastatic Pancreatic Cancer After Prior Therapy: SWOG S1115 Study Randomized Clinical Trial. Jama Oncology. PMID 27978579 DOI: 10.1001/Jamaoncol.2016.5383 |
0.308 |
|
| 2016 |
McCurry SM, Guthrie KA, Morin CM, Woods NF, Landis CA, Ensrud KE, Larson JC, Joffe H, Cohen LS, Hunt JR, Newton KM, Otte JL, Reed SD, Sternfeld B, Tinker LF, et al. Telephone-Based Cognitive Behavioral Therapy for Insomnia in Perimenopausal and Postmenopausal Women With Vasomotor Symptoms: A MsFLASH Randomized Clinical Trial. Jama Internal Medicine. PMID 27213646 DOI: 10.1001/Jamainternmed.2016.1795 |
0.309 |
|
| 2015 |
Siegel AB, El-Khoueiry AB, Finn RS, Guthrie KA, Goyal A, Venook AP, Blanke CD, Verna EC, Dove L, Emond J, Kato T, Samstein B, Busuttil R, Remotti H, Coffey A, et al. Phase I trial of sorafenib following liver transplantation in patients with high-risk hepatocellular carcinoma. Liver Cancer. 4: 115-25. PMID 26020033 DOI: 10.1200/Jco.2015.33.3_Suppl.401 |
0.313 |
|
| 2015 |
Campbell AP, Guthrie KA, Englund JA, Farney RM, Minerich EL, Kuypers J, Corey L, Boeckh M. Clinical Outcomes Associated With Respiratory Virus Detection Before Allogeneic Hematopoietic Stem Cell Transplant. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 61: 192-202. PMID 25847977 DOI: 10.1093/Cid/Civ272 |
0.343 |
|
| 2015 |
Erard V, Guthrie KA, Seo S, Smith J, Huang M, Chien J, Flowers ME, Corey L, Boeckh M. Reduced Mortality of Cytomegalovirus Pneumonia After Hematopoietic Cell Transplantation Due to Antiviral Therapy and Changes in Transplantation Practices. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 61: 31-9. PMID 25778751 DOI: 10.1093/Cid/Civ215 |
0.357 |
|
| 2015 |
Cassaday RD, Storer BE, Sorror ML, Sandmaier BM, Guthrie KA, Maloney DG, Rajendran JG, Pagel JM, Flowers ME, Green DJ, Rezvani AR, Storb RF, Press OW, Gopal AK. Long-term outcomes of patients with persistent indolent B cell malignancies undergoing nonmyeloablative allogeneic transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 21: 281-7. PMID 25445025 DOI: 10.1016/J.Bbmt.2014.10.024 |
0.382 |
|
| 2015 |
Rezvani AR, Storer BE, Guthrie KA, Schoch HG, Maloney DG, Sandmaier BM, Storb R. Impact of donor age on outcome after allogeneic hematopoietic cell transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 21: 105-12. PMID 25278458 DOI: 10.1016/J.Bbmt.2014.09.021 |
0.348 |
|
| 2015 |
Kopetz S, McDonough S, Morris VK, Lenz H, Magliocco AM, Atreya CE, Diaz LA, Allegra CJ, Lieu CH, Eckhardt SG, Semrad TJ, Kaberle K, Guthrie K, Hochster HS. S1406: Randomized phase II study of irinotecan and cetuximab with or without vemurafenib in BRAF-mutant metastatic colorectal cancer (mCRC). Journal of Clinical Oncology. 33: TPS790-TPS790. DOI: 10.1200/Jco.2015.33.3_Suppl.Tps790 |
0.321 |
|
| 2015 |
Cheung WY, Renfro LA, Yothers G, Gray RG, Haller DG, Twelves C, Andre T, Cutsem EV, Saltz L, Grothey A, Labianca R, Alberts SR, Schmoll H, Guthrie K, Gramont AD, et al. Determinants of early mortality in 37,568 colon cancer patients participating in 25 clinical trials of the ACCENT database. Journal of Clinical Oncology. 33: 6580-6580. DOI: 10.1200/Jco.2015.33.15_Suppl.6580 |
0.317 |
|
| 2015 |
Yao JC, Guthrie K, Moran C, Strosberg JR, Kulke MH, Chan JA, LoConte NK, McWilliams RR, Wolin EM, Mattar BI, McDonough S, Chen HX, Blanke CD, Hochster HS. SWOG S0518: Phase III prospective randomized comparison of depot octreotide plus interferon alpha-2b versus depot octreotide plus bevacizumab (NSC #704865) in advanced, poor prognosis carcinoid patients (NCT00569127). Journal of Clinical Oncology. 33: 4004-4004. DOI: 10.1200/Jco.2015.33.15_Suppl.4004 |
0.309 |
|
| 2015 |
Leichman CG, McDonough SL, Smalley SR, Billingsley KG, Lenz H, Beldner MA, Hezel AF, Velasco MR, Guthrie KA, Blanke CD, Hochster HS. S0713: A phase II study of cetuximab (CET) added to induction chemotherapy (ICT) of oxaliplatin (OX) and capecitabine (CAP), followed by neoadjuvant chemoradiation (NACR) for locally advanced rectal cancer (LARC). Journal of Clinical Oncology. 33: 3516-3516. DOI: 10.1200/Jco.2015.33.15_Suppl.3516 |
0.32 |
|
| 2014 |
Joffe H, Guthrie KA, LaCroix AZ, Reed SD, Ensrud KE, Manson JE, Newton KM, Freeman EW, Anderson GL, Larson JC, Hunt J, Shifren J, Rexrode KM, Caan B, Sternfeld B, et al. Low-dose estradiol and the serotonin-norepinephrine reuptake inhibitor venlafaxine for vasomotor symptoms: a randomized clinical trial. Jama Internal Medicine. 174: 1058-66. PMID 24861828 DOI: 10.1001/Jamainternmed.2014.1891 |
0.31 |
|
| 2014 |
Milano F, Shulman HM, Guthrie KA, Riffkin I, McDonald GB, Delaney C. Late-onset colitis after cord blood transplantation is consistent with graft-versus-host disease: results of a blinded histopathological review. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 20: 1008-13. PMID 24704386 DOI: 10.1016/J.Bbmt.2014.03.020 |
0.331 |
|
| 2014 |
Raj K, Pagliuca A, Bradstock K, Noriega V, Potter V, Streetly M, McLornan D, Kazmi M, Marsh J, Kwan J, Huang G, Getzendaner L, Lee S, Guthrie KA, Mufti GJ, et al. Peripheral blood hematopoietic stem cells for transplantation of hematological diseases from related, haploidentical donors after reduced-intensity conditioning. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 20: 890-5. PMID 24650678 DOI: 10.1016/J.Bbmt.2014.03.003 |
0.374 |
|
| 2014 |
Kim YJ, Guthrie KA, Waghmare A, Walsh EE, Falsey AR, Kuypers J, Cent A, Englund JA, Boeckh M. Respiratory syncytial virus in hematopoietic cell transplant recipients: factors determining progression to lower respiratory tract disease. The Journal of Infectious Diseases. 209: 1195-204. PMID 24368837 DOI: 10.1093/Infdis/Jit832 |
0.32 |
|
| 2014 |
Vande Vusse LK, Madtes DK, Guthrie KA, Gernsheimer TB, Curtis JR, Watkins TR. The association between red blood cell and platelet transfusion and subsequently developing idiopathic pneumonia syndrome after hematopoietic stem cell transplantation. Transfusion. 54: 1071-80. PMID 24033082 DOI: 10.1111/Trf.12396 |
0.303 |
|
| 2014 |
Cohen LS, Joffe H, Guthrie KA, Ensrud KE, Freeman M, Carpenter JS, Learman LA, Newton KM, Reed SD, Manson JE, Sternfeld B, Caan B, Freeman EW, LaCroix AZ, Tinker LF, et al. Efficacy of omega-3 for vasomotor symptoms treatment: a randomized controlled trial. Menopause (New York, N.Y.). 21: 347-54. PMID 23982113 DOI: 10.1097/Gme.0B013E31829E40B8 |
0.307 |
|
| 2014 |
Aspesberro F, Guthrie KA, Woolfrey AE, Brogan TV, Roberts JS. Outcome of pediatric hematopoietic stem cell transplant recipients requiring mechanical ventilation. Journal of Intensive Care Medicine. 29: 31-7. PMID 22904208 DOI: 10.1177/0885066612457343 |
0.341 |
|
| 2014 |
Emerson RO, Nikiforow S, Milano F, Sherwood AM, Papermaster A, Guthrie KA, Carlson CS, Warren EH, Ritz J, Robins H, Cutler CS, Delaney C. TCR Repertoire Diversity Assessed with Immunosequencing Is Associated with Patient Mortality Following Cord Blood Transplant Blood. 124: 1262-1262. DOI: 10.1182/Blood.V124.21.1262.1262 |
0.384 |
|
| 2014 |
Boeckh M, Xie H, Guthrie K, Pergam S, Mielcarek M, Fredricks D. 601Antibiotic Use Patterns Early After Hematopoietic Cell Transplantation (HCT) Influence the Risk of Viral Infections and Acute Graft-Versus-Host Disease (GVHD) Open Forum Infectious Diseases. 1. DOI: 10.1093/Ofid/Ofu051.68 |
0.318 |
|
| 2014 |
Cassaday RD, Storer BE, Sorror ML, Sandmaier BM, Guthrie KA, Hedin LM, Roden JE, Rajendran JG, Pagel JM, Maloney DG, Storb RF, Press OW, Gopal AK. Radioimmunotherapy-Augmented Nonmyeloablative Allogeneic Transplantation Improves Outcomes for Refractory Indolent B-Cell Non-Hodgkin Lymphoma: Results of an Adjusted Cohort Analysis Biology of Blood and Marrow Transplantation. 20. DOI: 10.1016/J.Bbmt.2013.12.087 |
0.323 |
|
| 2013 |
Cassaday RD, Guthrie KA, Budde EL, Thompson L, Till BG, Press OW, Chauncey TR, Pagel JM, Petersdorf SH, Palanca-Wessels MC, Philip M, Bensinger WI, Holmberg LA, Shustov A, Green DJ, et al. Specific features identify patients with relapsed or refractory mantle cell lymphoma benefitting from autologous hematopoietic cell transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 19: 1403-6. PMID 23871782 DOI: 10.1182/Blood.V120.21.3082.3082 |
0.347 |
|
| 2013 |
Delaney C, Emerson R, Milano F, Sherwood A, Papermaster A, Guthrie KA, Carlson C, Warren EH, Robins H. Evolution and Clinical Implications of the T Cell Repertoire Following Cord Blood Transplant Biology of Blood and Marrow Transplantation. 19: S201-S202. DOI: 10.1016/J.Bbmt.2012.11.220 |
0.302 |
|
| 2013 |
Burroughs L, Nemecek E, Torgerson T, Guthrie KA, Talano J, Domm J, Shimamura A, Carpenter PA, Skoda-Smith S, Englund JA, Baker KS, Storb RF, Woolfrey A. Treosulfan Based Conditioning Followed by Allogeneic Hematopoietic Cell Transplantation for Treatment of Patients with Non-Malignant Diseases: Preliminary Results of a Phase II Study Biology of Blood and Marrow Transplantation. 19. DOI: 10.1016/J.Bbmt.2012.11.119 |
0.362 |
|
| 2012 |
Kuypers J, Campbell AP, Guthrie KA, Wright NL, Englund JA, Corey L, Boeckh M. WU and KI polyomaviruses in respiratory samples from allogeneic hematopoietic cell transplant recipients. Emerging Infectious Diseases. 18: 1580-8. PMID 23017213 DOI: 10.3201/Eid1810.120477 |
0.352 |
|
| 2012 |
Li N, Guthrie KA, Storer BE, Martin PJ, Sale GE, Argenyi ZB, Myerson D. Keratinocyte dysplasia in hematopoietic stem cell transplantation recipients in the day-28-to-84 posttransplantation period. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 18: 1281-6. PMID 22326632 DOI: 10.1016/J.Bbmt.2012.02.001 |
0.354 |
|
| 2012 |
Delaney C, Emerson RO, Milano F, Sherwood A, Papermaster A, Guthrie KA, Carlson CS, Warren EH, Robins H. T Cell Repertoire Diversity After Umbilical Cord Transplant Predicts Mortality From Infection Blood. 120: 4202-4202. DOI: 10.1182/Blood.V120.21.4202.4202 |
0.339 |
|
| 2012 |
Campbell AP, Kuypers J, Callais CL, Guthrie KA, Englund JA, Boeckh M. Self Collection of Nasal Swabs for Diagnosis of Respiratory Viruses in Immunocompetent Volunteers and Hematopoietic Stem Cell Transplant (HCT) Recipients Biology of Blood and Marrow Transplantation. 18. DOI: 10.1016/J.Bbmt.2011.12.373 |
0.31 |
|
| 2011 |
Budde LE, Guthrie KA, Till BG, Press OW, Chauncey TR, Pagel JM, Petersdorf SH, Bensinger WI, Holmberg LA, Shustov AR, Green DJ, Maloney DG, Gopal AK. Mantle cell lymphoma international prognostic index but not pretransplantation induction regimen predicts survival for patients with mantle-cell lymphoma receiving high-dose therapy and autologous stem-cell transplantation. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 3023-9. PMID 21730271 DOI: 10.1200/Jco.2010.33.7055 |
0.385 |
|
| 2011 |
Gopal AK, Guthrie KA, Rajendran J, Pagel JM, Oliveira G, Maloney DG, Matesan MC, Storb RF, Press OW. ⁹⁰Y-Ibritumomab tiuxetan, fludarabine, and TBI-based nonmyeloablative allogeneic transplantation conditioning for patients with persistent high-risk B-cell lymphoma. Blood. 118: 1132-9. PMID 21508413 DOI: 10.1182/Blood-2010-12-324392 |
0.358 |
|
| 2011 |
Freeman EW, Guthrie KA, Caan B, Sternfeld B, Cohen LS, Joffe H, Carpenter JS, Anderson GL, Larson JC, Ensrud KE, Reed SD, Newton KM, Sherman S, Sammel MD, LaCroix AZ. Efficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial. Jama. 305: 267-74. PMID 21245182 DOI: 10.1001/Jama.2010.2016 |
0.325 |
|
| 2011 |
Nemecek ER, Guthrie KA, Sorror ML, Wood BL, Doney KC, Hilger RA, Scott BL, Kovacsovics TJ, Maziarz RT, Woolfrey AE, Bedalov A, Sanders JE, Pagel JM, Sickle EJ, Witherspoon R, et al. Conditioning with treosulfan and fludarabine followed by allogeneic hematopoietic cell transplantation for high-risk hematologic malignancies. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 17: 341-50. PMID 20685259 DOI: 10.1016/J.Bbmt.2010.05.007 |
0.346 |
|
| 2011 |
Thompson LA, Guthrie KA, Budde LE, Till BG, Press OW, Chauncey T, Pagel JM, Petersdorf SH, Bensinger WI, Holmberg L, Shustov AR, Green DJ, Maloney DG, Gopal AK. The Pre-Transplant Mantle Cell Lymphoma International Prognostic Index Predicts Overall and Progression-Free Survival Following High-Dose Therapy and Autologus Stem Cell Transplant for Mantle Cell Lymphoma Blood. 118: 2026-2026. DOI: 10.1182/Blood.V118.21.2026.2026 |
0.383 |
|
| 2010 |
Gammill HS, Guthrie KA, Aydelotte TM, Adams Waldorf KM, Nelson JL. Effect of parity on fetal and maternal microchimerism: interaction of grafts within a host? Blood. 116: 2706-12. PMID 20628146 DOI: 10.1097/Ogx.0B013E318216849C |
0.308 |
|
| 2010 |
Milano F, Campbell AP, Guthrie KA, Kuypers J, Englund JA, Corey L, Boeckh M. Human rhinovirus and coronavirus detection among allogeneic hematopoietic stem cell transplantation recipients. Blood. 115: 2088-94. PMID 20042728 DOI: 10.1182/Blood-2009-09-244152 |
0.314 |
|
| 2010 |
Guthrie KA, Yong M, Frieze D, Corey L, Fredricks DN. The impact of a change in antibacterial prophylaxis from ceftazidime to levofloxacin in allogeneic hematopoietic cell transplantation Bone Marrow Transplantation. 45: 675-681. PMID 19718062 DOI: 10.1038/Bmt.2009.216 |
0.34 |
|
| 2009 |
Changsirikulchai S, Myerson D, Guthrie KA, McDonald GB, Alpers CE, Hingorani SR. Renal thrombotic microangiopathy after hematopoietic cell transplant: role of GVHD in pathogenesis. Clinical Journal of the American Society of Nephrology : Cjasn. 4: 345-53. PMID 19144762 DOI: 10.2215/Cjn.02070508 |
0.333 |
|
| 2009 |
Budde LE, Guthrie KA, Till BG, Chauncey T, Press OW, Pagel JM, Petersdorf S, Bensinger W, Holmberg L, Shustov AR, Maloney DG, Gopal AK. Prognostic Factors On Outcome of Mantle Cell Lymphoma Patients Relapsing After Autologous Hematopoietic Stem Cell Transplantation. Blood. 114: 3327-3327. DOI: 10.1182/Blood.V114.22.3327.3327 |
0.39 |
|
| 2008 |
Nemecek ER, Sorror ML, Doney KC, Scott BL, Kovacsovics TJ, Maziarz RT, Woolfrey AE, Sanders J, O’Donnell PV, Guthrie K, Deeg HJ. A Regimen of Treosulfan and Fludarabine Followed by Allogeneic Hematopoietic Cell Transplantation (HCT) for High-Risk Hematologic Malignancies Is Associated with Low Treatment-Related Mortality Blood. 112: 2994-2994. DOI: 10.1182/Blood.V112.11.2994.2994 |
0.362 |
|
| 2008 |
Pan L, Guthrie KA, Till BG, Press OW, Pagel JM, Petersdorf S, Bensinger W, Holmberg L, Maloney DG, Gopal A. The Mantle Cell Lymphoma International Prognostic Index (MIPI) at Diagnosis Is Associated with Survival of Mantle Cell Lymphoma Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation. Blood. 112: 1143-1143. DOI: 10.1182/Blood.V112.11.1143.1143 |
0.378 |
|
| 2007 |
Erard V, Guthrie KA, Varley C, Heugel J, Wald A, Flowers ME, Corey L, Boeckh M. One-year acyclovir prophylaxis for preventing varicella-zoster virus disease after hematopoietic cell transplantation: no evidence of rebound varicella-zoster virus disease after drug discontinuation. Blood. 110: 3071-7. PMID 17515400 DOI: 10.1182/Blood-2007-03-077644 |
0.325 |
|
| 2007 |
Schubert MM, Eduardo FP, Guthrie KA, Franquin JC, Bensadoun RJ, Migliorati CA, Lloid CM, Eduardo CP, Walter NF, Marques MM, Hamdi M. A phase III randomized double-blind placebo-controlled clinical trial to determine the efficacy of low level laser therapy for the prevention of oral mucositis in patients undergoing hematopoietic cell transplantation. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 15: 1145-54. PMID 17393191 DOI: 10.1007/S00520-007-0238-7 |
0.356 |
|
| 2007 |
Hingorani S, Guthrie KA, Schoch G, Weiss NS, McDonald GB. Chronic kidney disease in long-term survivors of hematopoietic cell transplant Bone Marrow Transplantation. 39: 223-229. PMID 17290279 DOI: 10.1038/Sj.Bmt.1705573 |
0.339 |
|
| 2007 |
Schubert MM, Eduardo FP, Guthrie KA, Franquin JC, Bensadoun RJ, Migliorati CA, Hamdi M, Niccoli-Filho W. Abstract of the 20th International Anniversary MASCC/ISOO Symposium: A Phase III randomized double-blind placebo controlled clinical trial to determine the efficacy of low level laser therapy for the prevention of oral mucositis in patients undergoing hematopoietic cell transplantation Supportive Care in Cancer. 15: 1331-1332. DOI: 10.1007/S00520-007-0324-X |
0.35 |
|
| 2006 |
Erard V, Guthrie KA, Riddell S, Boeckh M. Impact of HLA A2 and cytomegalovirus serostatus on outcomes in patients with leukemia following matched-sibling myeloablative allogeneic hematopoietic cell transplantation. Haematologica. 91: 1377-83. PMID 17018388 DOI: 10.3324/%%X |
0.333 |
|
| 2006 |
Abdalla G, Guthrie KA, Sorror ML, Linenberger M. Apheresis Safety and Product Yield among Elderly Donors for Allogeneic Sibling Hematopoietic Cell Transplantation (HCT). Blood. 108: 5223-5223. DOI: 10.1182/Blood.V108.11.5223.5223 |
0.343 |
|
| 2006 |
Gopal AK, Rajendran JG, Pagel JM, Guthrie KA, Maloney DG, Appelbaum FR, Sandmaier BM, Storb RF, Press OW. A Phase II Trial of 90 Y-Ibritumomab Tiuxetan-Based Reduced Intensity Allogeneic Peripheral Blood Stem Cell (PBSC) Transplantation for Relapsed CD20+ B-Cell Non-Hodgkins Lymphoma (NHL). Blood. 108: 316-316. DOI: 10.1182/Blood.V108.11.316.316 |
0.39 |
|
| 2005 |
Panse JP, Heimfeld S, Guthrie KA, Maris MB, Maloney DG, Baril BB, Little MT, Chauncey TR, Storer BE, Storb R, Sandmaier BM. Allogeneic peripheral blood stem cell graft composition affects early T-cell chimaerism and later clinical outcomes after non-myeloablative conditioning British Journal of Haematology. 128: 659-667. PMID 15725088 DOI: 10.1111/J.1365-2141.2005.05363.X |
0.311 |
|
| 2005 |
Oehler VG, Radich JP, Storer B, Blume KG, Chauncey T, Clift R, Snyder DS, Forman SJ, Flowers ME, Martin P, Guthrie KA, Negrin RS, Appelbaum FR, Bensinger W. Randomized trial of allogeneic related bone marrow transplantation versus peripheral blood stem cell transplantation for chronic myeloid leukemia. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 11: 85-92. PMID 15682068 DOI: 10.1016/J.Bbmt.2004.09.010 |
0.378 |
|
| 2004 |
Nichols WG, Guthrie KA, Corey L, Boeckh M. Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 39: 1300-6. PMID 15494906 DOI: 10.1086/425004 |
0.318 |
|
| 2004 |
Fukuda T, Boeckh M, Guthrie KA, Mattson DK, Owens S, Wald A, Sandmaier BM, Corey L, Storb RF, Marr KA. Invasive aspergillosis before allogeneic hematopoietic stem cell transplantation: 10-year experience at a single transplant center. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 10: 494-503. PMID 15205670 DOI: 10.1016/J.Bbmt.2004.02.006 |
0.381 |
|
| 2004 |
Adams KM, Holmberg LA, Leisenring W, Fefer A, Guthrie KA, Tylee TS, McDonald GB, Bensinger WI, Nelson JL. Risk factors for syngeneic graft-versus-host disease after adult hematopoietic cell transplantation. Blood. 104: 1894-7. PMID 15117763 DOI: 10.1182/Blood-2004-02-0508 |
0.337 |
|
| 2004 |
Lambert NC, Erickson TD, Yan Z, Pang JM, Guthrie KA, Furst DE, Nelson JL. Quantification of maternal microchimerism by HLA-specific real-time polymerase chain reaction: studies of healthy women and women with scleroderma. Arthritis and Rheumatism. 50: 906-14. PMID 15022334 DOI: 10.1002/Art.20200 |
0.311 |
|
| 2004 |
Frieze DA, Guthrie KA, Nichols WG. Ceftazidime Versus Levofloxacin for Antibacterial Prophylaxis in Allogeneic Hematopoietic Cell Transplant (HCT) Recipients. Blood. 104: 3166-3166. DOI: 10.1182/Blood.V104.11.3166.3166 |
0.341 |
|
| 2004 |
Adams KM, Holmberg LA, Leisenring W, Guthrie KA, Tylee TS, McDonald GB, Bensinger WI, Nelson JL. Risk factors for syngeneic graft-versus-host disease in adult hematopoietic stem cell transplants Biology of Blood and Marrow Transplantation. 10: 53. DOI: 10.1016/J.Bbmt.2003.12.269 |
0.318 |
|
| 2003 |
Fukuda T, Hackman RC, Guthrie KA, Sandmaier BM, Boeckh M, Maris MB, Maloney DG, Deeg HJ, Martin PJ, Storb RF, Madtes DK. Risks and outcomes of idiopathic pneumonia syndrome after nonmyeloablative and conventional conditioning regimens for allogeneic hematopoietic stem cell transplantation. Blood. 102: 2777-85. PMID 12855568 DOI: 10.1182/Blood-2003-05-1597 |
0.362 |
|
| 2003 |
Akpek G, Lee SJ, Flowers ME, Pavletic SZ, Arora M, Lee S, Piantadosi S, Guthrie KA, Lynch JC, Takatu A, Horowitz MM, Antin JH, Weisdorf DJ, Martin PJ, Vogelsang GB. Performance of a new clinical grading system for chronic graft-versus-host disease: a multicenter study. Blood. 102: 802-9. PMID 12714524 DOI: 10.1182/Blood-2002-10-3141 |
0.318 |
|
| 2003 |
Stirewalt DL, Guthrie KA, Beppu L, Bryant EM, Doney K, Gooley T, Appelbaum FR, Radich JP. Predictors of relapse and overall survival in Philadelphia chromosome-positive acute lymphoblastic leukemia after transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 9: 206-12. PMID 12652472 DOI: 10.1053/Bbmt.2003.50025 |
0.303 |
|
| 2003 |
Nichols WG, Guthrie KA, Corey L, Boeckh M. 34 Influenza infections after stem cell transplantation (SCT): Risk factors, mortality and the effect of antiviral therapy Biology of Blood and Marrow Transplantation. 9: 73-74. DOI: 10.1016/S1083-8791(03)80035-6 |
0.309 |
|
| 2003 |
Fukuda T, Hackman RC, Guthrie KA, Carter RA, Sandmaier BM, Davis C, Martin PJ, Storb RF, Madtes DK. 7Risks and outcomes of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation: The intensity of the conditioning regimen outweighs the effect of acute graft-versus-host disease Biology of Blood and Marrow Transplantation. 9: 65. DOI: 10.1016/S1083-8791(03)80008-3 |
0.338 |
|
| 2002 |
Lambert NC, Lo YM, Erickson TD, Tylee TS, Guthrie KA, Furst DE, Nelson JL. Male microchimerism in healthy women and women with scleroderma: cells or circulating DNA? A quantitative answer. Blood. 100: 2845-51. PMID 12351394 DOI: 10.1182/Blood-2002-01-0295 |
0.332 |
|
| Show low-probability matches. |